Synonyms: Anaspaz; Atropine Sulfate, 3(S)-endo-Isomer; hyoscyamine; SR-01000799139; I06-2035; J-000364; SR-01000799139-2; BRD-K40530731-001-02-5; BRD-K40530731-001-11-6; UNII-7C0697DR9I component RKUNBYITZUJHSG-FXUDXRNXSA-N; (3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate; (8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)(2R)-3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate; (-)-Hyoscyamine; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenyl-propanoate; (2S)-2-Phenyl-3-hydroxypropionic acid (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3beta-yl ester; [3(S)-endo]-a-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; l-Atropine; Cystospaz; Levsin; 1-Hyoscyamine; Actoferrin; ATROPINE; Cytospaz; 101-31-5; Anaspaz; l-Hyopscyamine; L-Hyoscamine; L-Hyoscyamin; Hyoscyamine sulfate; Hyoscyamine [BAN]; Hyoscyamine hydrochloride; D0NZ3Q; HYOSCYAMINE HYDROBROMIDE; Hyoscyamine sulfate anhydrous; Daturine; Atropine, 3(S)-endo-Isomer; Tropic acid, ester with tropine; NSC61808; Atropine Sulfate, 3(S)-endo-Isomer; C17-H23-N-O3; CID154417; Tropic acid, (-)-, ester with tropine; ACN-047533; CS-O-01637; A8369; (S)-Atropine; D064692; (-)-Hyoscyamine, 97%, from Atropa belladonna L. - 10MG 10mg; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; (alpha S)-alpha-(Hydroxymethyl)benzeneacetic acid (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; 6835-16-1; Benzeneacetic acid, .alpha.-(hydroxymethyl)-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, [3(S)-endo]-; Benzeneacetic acid, .alpha.-(hydroxymethyl)-, endo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (.alpha.S)-; Duboisine; (-)-Atropine; L-Tropine tropate; (S)-(-)-Hyoscyamine; Hyoscyamine (L); Atropine, 3(S)-endo-Isomer; UNII-PX44XO846X; Tropine, (-)-tropate; Levbid; PX44XO846X; Levsinex SR; CHEBI:17486; Hyoscyamine, l-; [3(S)-endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; (1R,5S)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL (2R)-3-HYDROXY-2-PHENYLPROPANOATE; (2S)-(1R,5S)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate; Cytospaz; Hyocyamine; tropan-3alpha-yl (2S)-3-hydroxy-2-phenylpropanoate; Tropine, (-)-tropate (ester); HSDB 3552; Hyospaz; Hyosyne; EINECS 202-933-0; Symax Duotab; Levsin SL; (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; Hyoscyamine; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate; Symax SL; Symax SR; OIN; SMR000718747; Hyoscyamine [USP:BAN]; 1alphaH,5alphaH-Tropan-3alpha-ol (-)-tropate (ester); Hyoscyamin; Hyoscyaminum; Daturin; Hyoscyamine Hydrobromide; (leo)-atropine; (S)atropine; 2arm; Tropine-L-tropate; (leo)-hyoscyamine; hyoscyamine-daturine; Benzeneacetic acid, .alpha.-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (.alpha.S)-; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (alphaS)-; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (alphaS)-; Prestwick_273; Hyoscyamine Hydrochloride; Hyoscyamine (USP); MFCD00067306; ENDO-ATROPINE; (S)-(leo)-hyoscyamine; Anaspaz, Levbid, Levsin; Prestwick3_000233; ZINC56; AC1L4C8O; SCHEMBL41316; BSPBio_000305; Hyoscyamine Sulfate; MLS001304011; MLS002154242; MLS002222193; SCHEMBL249586; BPBio1_000337; SCHEMBL1649244; CHEMBL1234973; CHEMBL1331216; CHEMBL2449003; CHEBI:92712; Hyoscyamine Sulfate Anhydrous; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate; RKUNBYITZUJHSG-FXUDXRNXSA-N; HMS2095P07; HMS2231N11; HMS3712P07; Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, (3(S)-endo)-; AKOS015896332; AKOS016843532; ZINC100009280; ZINC100068360; L-Hyoscyamine; CCG-220233; DB00424; MCULE-1764209130; NCGC00179608-01; AJ-07844; ST24034062; 5908-99-6; 5934-50-9; C02046; D00147;